Chemomab Therapeutics Ltd
NASDAQ:CMMB
Chemomab Therapeutics Ltd
Depreciation & Amortization
Chemomab Therapeutics Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
Depreciation & Amortization
$67k
|
CAGR 3-Years
50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Depreciation & Amortization
$1.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Depreciation & Amortization
$12.7m
|
CAGR 3-Years
38%
|
CAGR 5-Years
27%
|
CAGR 10-Years
16%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Depreciation & Amortization
$705k
|
CAGR 3-Years
10%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Depreciation & Amortization
$56k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Depreciation & Amortization
₪2.8m
|
CAGR 3-Years
37%
|
CAGR 5-Years
70%
|
CAGR 10-Years
29%
|
See Also
What is Chemomab Therapeutics Ltd's Depreciation & Amortization?
Depreciation & Amortization
67k
USD
Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Depreciation & Amortization amounts to 67k USD.
What is Chemomab Therapeutics Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
50%
Over the last year, the Depreciation & Amortization growth was 12%. The average annual Depreciation & Amortization growth rates for Chemomab Therapeutics Ltd have been 50% over the past three years .